PRKAR1A and primary pigmented nodular adrenocortical disease: In addition to the cAMP/PKA pathway, involvement of the Wnt/beta-catenin pathway was also reported in a study including 13 patients with PPNAD or sporadic cortisol-secreting adenomas (ACAs) with PRKAR1A somatic mutation.